Specialty Pharmacy

Chromosomal instability may be a potential biomarker for cancer prognosis.

Top news of the day from across the health care landscape.

The revolutionary CRISPR/Cas9 gene editing tool can target and inactivate cancer mutations, leading to more personalized therapies for patients.

Autumn Bagwell, PharmD, BCPS, clinical pharmacist at Vanderbilt Specialty Pharmacy, discusses the components of an effective patient management program to optimize adherence.

Pembrolizumab (Keytruda) was previously granted Breakthrough Therapy Designation for advanced non-small cell lung cancer.

National Association of Specialty Pharmacy notes that providers should focus on delivering high quality care to patients without focusing on high price tags.

Top news of the day from across the health care landscape.

New evidence suggests that oral supplements taken with asthma treatments significantly reduce the risk for asthma attack.

Preventative strategies necessary to reduce hospital admissions resulting from cancer treatments, medical complications, accidents, and self-harm.

Vitamin A metabolite in the gut kills off cancer cells.

Higher levels of transport genes are an indicator of patients likely to be resistant to therapy with tamoxifen.

Sheila Arquette, RPh, director of Pharmacy Services at Independent Health, discusses the challenges of access to high cost specialty medications.

Top articles of the week from The American Journal of Pharmacy Benefits.

Top news of the week in oncology, and cancer drug development.

Use of standing desks in elementary schools may reduce long-term health concerns.

Therapies that target certain gut bacteria may prevent complications and improve the efficiency of antiretroviral therapy.

Genetically engineered mice lacking a specific protein developed diabetes at a faster rate.

Experimental drug shows promise killing triple negative breast cancer cells.

Top news of the week on Specialty Pharmacy Times.

Eric Peacock, co-found and CEO of MyHealthTeams, discusses specialty pharmacy patient engagement on social media.

Top news of the day from across the health care landscape.

Hepatitis C causes inflexible scar tissue to form in the liver.

Atezolizumab (Tecentriq) monoclonal antibody that binds to the PD-L1 protein in non-small cell lung cancer.

New treatment for mast cell leukemia could improve quality-of-life and overall survival.

Andexanet can reverse anticoagulated-related bleeding in patients with acute major bleeding.

Several mechanisms can lead to BRAF inhibitor resistance among patients with melanoma.

Top news of the day from across the health care landscape.

Suzette DiMascio, CHE, CMCE, CPC, president and CEO of the CSI Specialty Group, discusses difficulties for an independent specialty pharmacy in the current landscape.